BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11018583)

  • 21. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.
    Silber JR; Bobola MS; Blank A; Schoeler KD; Haroldson PD; Huynh MB; Kolstoe DD
    Clin Cancer Res; 2002 Sep; 8(9):3008-18. PubMed ID: 12231548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AP endonuclease 1 coordinates flap endonuclease 1 and DNA ligase I activity in long patch base excision repair.
    Ranalli TA; Tom S; Bambara RA
    J Biol Chem; 2002 Nov; 277(44):41715-24. PubMed ID: 12200445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histology-specific expression of a DNA repair protein in pediatric rhabdomyosarcomas.
    Thomson B; Tritt R; Davis M; Kelley MR
    J Pediatr Hematol Oncol; 2001 May; 23(4):234-9. PubMed ID: 11846302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.
    Thakur S; Sarkar B; Cholia RP; Gautam N; Dhiman M; Mantha AK
    Exp Mol Med; 2014 Jul; 46(7):e106. PubMed ID: 25033834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Going ape as an approach to cancer therapeutics.
    Bapat A; Fishel ML; Kelley MR
    Antioxid Redox Signal; 2009 Mar; 11(3):651-68. PubMed ID: 18715143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation.
    Hsieh MM; Hegde V; Kelley MR; Deutsch WA
    Nucleic Acids Res; 2001 Jul; 29(14):3116-22. PubMed ID: 11452037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
    Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
    Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
    J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multifunctional APE1 DNA repair-redox signaling protein as a drug target in human disease.
    Caston RA; Gampala S; Armstrong L; Messmann RA; Fishel ML; Kelley MR
    Drug Discov Today; 2021 Jan; 26(1):218-228. PubMed ID: 33148489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation.
    Tell G; Zecca A; Pellizzari L; Spessotto P; Colombatti A; Kelley MR; Damante G; Pucillo C
    Nucleic Acids Res; 2000 Mar; 28(5):1099-105. PubMed ID: 10666449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice.
    Fujimura M; Morita-Fujimura Y; Narasimhan P; Copin JC; Kawase M; Chan PH
    Stroke; 1999 Nov; 30(11):2408-15. PubMed ID: 10548678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
    Kaur G; Cholia RP; Mantha AK; Kumar R
    J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity.
    Ludwig DL; MacInnes MA; Takiguchi Y; Purtymun PE; Henrie M; Flannery M; Meneses J; Pedersen RA; Chen DJ
    Mutat Res; 1998 Oct; 409(1):17-29. PubMed ID: 9806499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.
    Curtis CD; Thorngren DL; Ziegler YS; Sarkeshik A; Yates JR; Nardulli AM
    Mol Endocrinol; 2009 Sep; 23(9):1346-59. PubMed ID: 19460860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme.
    Xanthoudakis S; Miao G; Wang F; Pan YC; Curran T
    EMBO J; 1992 Sep; 11(9):3323-35. PubMed ID: 1380454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of apurinic/apyrimidinic endonuclease expression after transient global cerebral ischemia in rats: implication of the failure of DNA repair in neuronal apoptosis.
    Kawase M; Fujimura M; Morita-Fujimura Y; Chan PH
    Stroke; 1999 Feb; 30(2):441-8; discussion 449. PubMed ID: 9933285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis.
    Kaina B; Ochs K; Grösch S; Fritz G; Lips J; Tomicic M; Dunkern T; Christmann M
    Prog Nucleic Acid Res Mol Biol; 2001; 68():41-54. PubMed ID: 11554312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
    Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
    Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.